Eli Lilly: New Alzheimer ' s treatment slows disease in late-stage study

Pharmaceutical giant Eli Lilly said Wednesday results from a Phase 3 study on its Alzheimer ' s treatment show it slowed clinical cognitive and functional decline by 35% compared with a placebo.

Source: Health News - UPI.com - May 3, 2023 Category: Consumer Health News Source Type: news